Contra Costa County Header
File #: 24-4391    Version: 1 Name:
Type: Consent Item Status: Passed
File created: 11/25/2024 In control: BOARD OF SUPERVISORS
On agenda: 12/17/2024 Final action: 12/17/2024
Title: APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Sanofi Pasteur Inc. in an amount not to exceed $575,000 for the purchase of vaccines and injectable medications at the Contra Costa Regional Medical Center and Health Centers for the period January 1, 2025 through December 31, 2025. (100% Hospital Enterprise Fund I)
To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Purchase Order with Sanofi Pasteur Inc.
?Recommendation of the County Administrator ? Recommendation of Board Committee


RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Sanofi Pasteur Inc. in an amount not to exceed $575,000 for the purchase of vaccines and injectable medications at the Contra Costa Regional Medical Center (CCRMC) and Health Centers, for the period from January 1, 2025 through December 31, 2025.

FISCAL IMPACT:
Approval of this action will result in expenditures of up to $575,000 and will be funded by Hospital Enterprise Fund I revenues.

BACKGROUND:
Sanofi Pasteur Inc. furnishes pharmaceuticals for patient care provided in the hospital and clinics. These vaccines and other injectable medications are essential for patient care. Sanofi is the maker of critical injectables for the hospital including Insulin for Type I and Type II diabetic patients, vaccines, and different immune globulin formulations including Immune globulin intravenous (IVIG), a life-saving medication used to treat primary immunodeficiency to reduce the risk of infection in individuals with poorly functioning immune systems. IVIG is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysms caused by a weakening of the main artery in the heart associated with Kawasaki syndrome.

On November 28, 2023, the Board of Supervisors approved agenda item C.32 to execute a purchase order (#29227) with Sanofi Pasteur Inc. in the amount of $575,000 for the period of January 1, 2024 through December 31, 2024.

On November 25, 2024, the Purchasing Agent approved the use of Sanofi Pasteur Inc. to purchase essential vaccines and other pharmaceuticals for patient care through December 31, 2025.

CONSEQUENCE OF NEGATIVE ACTION:
If this act...

Click here for full text